INTER PHARMA PUBLIC COMPANY LIMITEDSET: IP🇹🇭 TH

Financial Information

Key Financial Highlights

As at 2026-09-30 · Unit: M.Baht

Item20242025H1 20269M 2026
Total revenue1,9122,2141,1191,707
Net profit37.28122.3868.95117.12
Total assets3,0213,2393,2473,267
Total liabilities866.4939.83913.93879.99
Shareholders' equity1,9372,0592,0842,132
EPS (Baht)0.060.20.110.19
ROE (%)1.946.136.736.85
ROA (%)2.486.096.76.9
Net profit margin (%)1.976.157.027.74
D/E (times)0.40.410.390.37
ItemY/E 2023Dec 2023Y/E 2024Dec 2024Y/E 2025Dec 20256M/2025Jun 20256M/2026Jun 2026
Cash And Cash Equivalents412.39184.6280.64278.93241.5
A/R Net425.06440.5446.77408.57442.41
Inventories345.27329.91349.72345.13415.88
Current Assets1,202.85981.81,105.921,060.061,129.46
PP&E Net822.371,042.911,096.921,066.91,098.01
Non-Current Assets1,749.522,038.762,132.892,079.112,117.82
Total Assets2,952.373,020.563,238.813,139.183,247.27
OD4062.78100106.4481.9
A/P Net321.51324.68378.5330.71391.5
Current portion of LT54.4381.8595.2596.5593.54
Current Liabilities478.75526.29638.02597.57631.5
Non-Current Liabilities355.9340.11301.81327.19282.43
Total Liabilities834.65866.4939.83924.77913.93
Authorized Capital243.36378.39378.39378.39304.92
Paid-Up Capital186.26302.67302.67302.67302.67
Premium (Discount) on Share Capital1,479.71,479.71,479.71,479.71,479.7
Retained Earnings (Deficit)225.25132.41254.69186.57279.45
Treasury Stock—————
Shares Of The Company Held By Subsidiaries—————
Other Components Of Equity21.9821.9821.9821.9821.98
- Surplus (Deficits)3.73.73.73.73.7
Shareholders' Equity1,913.191,936.762,059.041,990.922,083.8
Minority Interest204.53217.4239.94223.49249.54

Auditor's Reports

ReportDate of submissionAuditor’s opinionAuditor’s firm
Q2 /202614 Aug 2026Unqualified opinionEY OFFICE LIMITED
Q1 /202611 May 2026Unqualified opinionEY OFFICE LIMITED
Yearly 20252 Mar 2026Unqualified opinion with an emphasis of mattersEY OFFICE LIMITED
Q3 /202511 Nov 2025Unqualified opinion with an emphasis of mattersEY OFFICE LIMITED